Ignite Creation Date:
2024-05-06 @ 1:41 AM
Last Modification Date:
2024-10-26 @ 11:08 AM
Study NCT ID:
NCT01870505
Status:
COMPLETED
Last Update Posted:
2022-03-02
First Post:
2013-06-03
Brief Title:
BYL719 Plus Letrozole or Exemestane for Patients With Hormone-Receptor Positive Locally-Advanced Unresectable or Metastatic Breast Cancer
Sponsor:
Organization:
Memorial Sloan Kettering Cancer Center